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Abstract
Objective: In Parkinson’s disease (PD), commonly reported risk factors for malnutrition in other populations commonly
occur. Few studies have explored which of these factors are of particular importance in malnutrition in PD. The aim was to
identify the determinants of nutritional status in people with Parkinson’s disease (PWP).
Methods: Community-dwelling PWP (.18 years) were recruited (n = 125; 73M/52F; Mdn 70 years). Self-report assessments
included Beck’s Depression Inventory (BDI), Spielberger Trait Anxiety Inventory (STAI), Scales for Outcomes in Parkinson’s
disease – Autonomic (SCOPA-AUT), Modified Constipation Assessment Scale (MCAS) and Freezing of Gait Questionnaire
(FOG-Q). Information about age, PD duration, medications, co-morbid conditions and living situation was obtained.
Addenbrooke’s Cognitive Examination (ACE-R), Unified Parkinson’s Disease Rating Scale (UPDRS) II and UPDRS III were
performed. Nutritional status was assessed using the Subjective Global Assessment (SGA) as part of the scored Patient-
Generated Subjective Global Assessment (PG-SGA).
Results: Nineteen (15%) were malnourished (SGA-B). Median PG-SGA score was 3. More of the malnourished were elderly
(84% vs. 71%) and had more severe disease (H&Y: 21% vs. 5%). UPDRS II and UPDRS III scores and levodopa equivalent daily
dose (LEDD)/body weight(mg/kg) were significantly higher in the malnourished (Mdn 18 vs. 15; 20 vs. 15; 10.1 vs. 7.6
respectively). Regression analyses revealed older age at diagnosis, higher LEDD/body weight (mg/kg), greater UPDRS III
score, lower STAI score and higher BDI score as significant predictors of malnutrition (SGA-B). Living alone and higher BDI
and UPDRS III scores were significant predictors of a higher log-adjusted PG-SGA score.
Conclusions: In this sample of PWP, the rate of malnutrition was higher than that previously reported in the general
community. Nutrition screening should occur regularly in those with more severe disease and depression. Community
support should be provided to PWP living alone. Dopaminergic medication should be reviewed with body weight changes.
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Introduction
Well-documented risk factors for poor nutrition in community-
dwelling adults include older age [1,2], living alone [3], dementia
[4,5], depression [1,3,5], anorexia [6], gastrointestinal dysfunction
(dysphagia, slow gastric emptying, constipation) [7,8], poor
functional status [3,5], co-morbidities [9] and polypharmacy [3].
In Parkinson’s disease (PD), these risk factors are common, often
occurring more frequently than in age-matched controls, including
dementia [10], depression [11] and gastrointestinal disorders
(dysphagia [12,13], early satiety [12] and constipation [13]). While
limited research has been conducted to determine the predictors of
malnutrition in PD, it has been reported that depression and
constipation are significant predictors of malnutrition [14].
Factors that are specific to PD that may place someone at
nutritional risk include the motor symptoms of bradykinesia,
akinesia, rigidity, and tremor which can impair functional ability
and make it difficult to ambulate [15], shop, cook, and feed
independently [16,17]. Decreased hand-mouth coordination and
difficulties completing fine movements, such as that required with
utensils [15] can be present.
Decreased weight and body mass indices are not associated with
longer disease duration [18]. However, it has been reported that
disease severity (Hoehn & Yahr) is associated with decreased body
mass indices (BMI) [18], but Hoehn & Yahr classification does not
significantly predict a diagnosis of malnutrition using the Mini-
Nutritional Assessment (MNA) [14].
The use of levodopa as medical management for PD can
introduce side effects such as nausea & vomiting and weight loss
[19]. Higher intakes of levodopa have been associated with lower
BMIs [20], particularly higher intakes per kilogram of body weight
[21]. This could potentially be due to the fact that higher levodopa
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dosages increase the risk of developing dyskinesias [22] and
therefore increase energy expenditure and energy requirements
[21].
While many studies have investigated relationships between
these potential risk factors and decreased BMIs, few have explored
the relationship with nutritional status using a diagnosis of
malnutrition based on a nutrition assessment tool. BMI is not
sensitive enough on its own to identify malnutrition [23], and
nutrition assessment tools incorporate anthropometry, weight
history, dietary intake and physical signs of malnutrition to
diagnosis malnutrition.
Malnutrition is under-recognised across all healthcare settings
[24] but particularly in the community where, firstly, there is
limited data on the extent of malnutrition and, secondly, access to
people at nutrition risk can be difficult [24,25]. Poor nutritional
status is an independent risk factor for hospitalization [3], and
community dwelling adults just transitioning to aged care have
poorer nutritional status than other adults in the community [26].
Therefore, identifying and understanding the issue in the
community can assist with intervention planning and implementa-
tion which may prevent or delay declines in nutritional status and
potentially admittance to hospital or aged care [24]. Raising
awareness of the issue of malnutrition in people with Parkinson’s
disease (PWP) in the community, therefore, may assist with
advocacy for nutrition screening by health professionals with
whom they have regular contact.
Therefore, the aim of the current study was to identify which
factors predict nutritional status in PWP free-living in the
community when measured by the Subjective Global Assessment
(SGA), a valid nutrition assessment tool for use in the community
[24] and previously used to assess nutritional status in community-
dwelling elderly [25], oncology patients [27,28], and patients with
chronic kidney disease [29,30].
Methods
Recruitment process
Community-dwelling PWP, aged .18 years were recruited
between February and August 2011 using a variety of methods
including media releases in local newspapers and inclusion in the
quarterly newsletter issued by Parkinson’s Queensland, Inc, the
local non-profit organization [31]. Potential participants initiated
Table 1. Demographic and motor symptom characteristics of the participants compared between nutritional states.
SGA Classification
A (Well-nourished) B (Moderately malnourished)
(n=106) (n =19)
Median (Range) Median (Range)
Age (years) 69.0 (35.0–92.0) 74.0 (61.0–87.0)
PG-SGA score 2 (0–15)* 8 (4–15)*
Living Situation (with others) 90 (85%) 15 (79%)
PD Duration (years) 6.0 (0.0–31.0) 7.0 (1.0–26.0)
(n = 105)
Age at diagnosis (years) 63.0 (28.0–84.0) 66.0 (43.0–84.0)
(n = 105)
LEDD (mg) 574.25 (0.0–2296.0) 600.0 (75.021600.0)
LEDD/weight (mg/kg) 7.6 (0.0–27.8)* 10.1(1.6–27.9)*
no. of prescription medications 5 (0–16) 5 (0–12)
no. of comorbid conditions 1 (0–6) 1 (0–3)
H&Y{ * *
0 2 (2%) 0 (0%)
1 27 (25%) 1 (5%)
2 37 (35%) 7 (37%)
3 35 (33%) 7 (37%)
4 5 (5%) 3 (16%)
5 0 (0%) 1 (5%)
Less severe PD (H&Y 0–3){ 101 (96%)* 15 (79%)*
Severe PD (H&Y 4–5){ 5 (4%)* 4 (21%)*
UPDRS III 15 (1–37)* 20 (11–39)*
(n = 17)
UPDRS II 13 (2–35)* 18 (7–38)*
FOG-Q 7 (0–23) 7 (0–17)
{Reported as frequencies (percentages).
*Statistically significant difference between SGA classifications (p,0.05).
Abbreviations: H&Y =Hoehn & Yahr; FOG-Q= Freezing of Gait Questionnaire; LEDD= levodopa equivalent daily doses; PD =Parkinson’s disease; PG-SGA= Patient
Generated Subjective Global Assessment; SGA= Subjective Global Assessment; UPDRS =Unified Parkinson’s Disease Rating Scale.
doi:10.1371/journal.pone.0057986.t001
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contact with the research team to participate. Participants were
excluded only if they resided in an aged care/long-term care
facility. All other consenting adults .18 years with PD were
included. Geographical location was limited to areas within
,2 hour driving distance from Brisbane, Queensland, Australia.
Ethics statement
Informed written consent was obtained as per protocol
approved by the Queensland University of Technology Human
Research Ethics Committee, which also approved the study
(#1000001150).
Setting
Data collection was completed either at Queensland University
of Technology (n = 15) or participants’ homes (n = 110).
Demographic information and medical history
Birth date, disease duration since diagnosis (PD duration),
medications, co-morbid conditions and living situation were
obtained from the participant and/or their spouse. The number
of prescription medications and number of comorbid conditions
were each split into 2 categories: (,4 medications, $4 medica-
tions) and (,4 conditions, $4 conditions) [5]. Levodopa
equivalent daily doses (LEDD) [32] and LEDD per kilogram
body weight (mg/kg) (levodopa/body weight) were calculated.
Cognitive function and Parkinson’s disease rating scales
Cognitive function was measured using the Addenbrooke’s
Cognitive Examination (ACE-R), which includes the Mini-Mental
State Examination (MMSE). The Unified Parkinson’s Disease
Rating Scale (UPDRS) motor sub-scale (III) was conducted
following a medication dose, generally approaching optimal state,
to assess disease severity. The postural stability component of the
assessment was not completed to ensure the safety of the
Table 2. Non-motor symptoms of the participants compared between nutritional states.
SGA Classification
A (Well-nourished) B (Moderately malnourished)
(n=106) (n =19)
Median (Range) Median (Range)
ACE-R 88 (55–100) 84 (64–95)
(n = 105) (n = 17)
MMSE 29 (22–30)* 27 (24–30)*
(n = 105) (n = 17)
BDI 8 (0–34)* 14 (5–29)*
(n = 105)
STAI 37.5 (20–63) 36 (25–60)
(n = 105) (n = 18)
MCAS Satisfaction 4 (1–5) 3 (1–5)
(n = 104)
MCAS 3 (0–10) 5 (0–8)
(n = 105)
SCOPA-AUT 15 (3–50) 18 (3–33)
(n = 105)
SCOPA-AUT gastrointestinal sub-score 4 (0–16)* 6 (0–15)*
(n = 105)
SCOPA-AUT urinary sub-score 5 (0–18) 7 (2–11)
(n = 105)
SCOPA-AUT cardiovascular sub-score 1 (0–6) 0 (0–4)
(n = 105)
SCOPA-AUT thermoregulatory sub-score 2 (0–9) 3 (0–6)
(n = 105)
SCOPA-AUT pupillomotor sub-score 1 (0–3) 0 (0–2)
(n = 105)
SCOPA-AUT sexual sub-score 0 (0–6) 1 (0–6)
(n = 105)
*Statistically significant difference between SGA classifications (p,0.05).
Abbreviations: ACE-R =Addenbrooke’s Cognitive Examination-Revised; BDI = Beck’s Depression Inventory; MCAS=Modified Constipation Assessment Scale;
MMSE =Mini-Mental State Examination; SCOPA-AUT= Scales for Outcomes in Parkinson’s disease – Autonomic; SGA= Subjective Global Assessment; STAI = Spielberger
Trait Anxiety Inventory.
doi:10.1371/journal.pone.0057986.t002
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participants and the researcher. The UPDRS Activities of Daily
Living sub-scale (UPDRS II) was also completed. The Hoehn and
Yahr (H&Y) scale, which is a five-point scale (1–5) with a higher
rating on the scale indicating a greater amount of disability and
impairment, was also measured. The H&Y scores were also split
into 2 groups (less severe PD H&Y 0–3, severe PD H&Y 4–5).
Anthropometry and nutritional status
Body weight was measured to the nearest 0.1 kg (Tanita HD-
316, Japan) in light clothing, without shoes. Nutritional status was
measured by a dietitian using the SGA, resulting in a categorisation
of nutrition status: SGA-A (well nourished), SGA-B (moderately
malnourished) or SGA-C (severely malnourished) [33]. The scored
Patient-Generated Subjective Global Assessment (PG-SGA) was
also completed, providing a score of the total of four worksheet
scores, with a higher score indicating poorer nutritional status
[34]. PG-SGA Worksheet 1, completed by the participant,
provides a score for recent changes in weight, food intake,
nutrition impact symptoms (lack of appetite, nausea/vomiting,
changes in smell and taste, constipation, dry mouth, mouth sores,
early satiety, pain, difficulties swallowing), and functional capacity.
Worksheet 2 provides a score for medical conditions and age.
Worksheet 3 provides a score for components of metabolic stress,
and finally Worksheet 4 consists of the physical examination score.
The assessor completes worksheets 2, 3 and 4.
Self-completed questionnaires
Participants received the Beck’s Depression Inventory (BDI), the
Spielberger Trait Anxiety Inventory (STAI), the Scales for
Outcomes in Parkinson’s disease – Autonomic (SCOPA-AUT),
the Modified Constipation Assessment Scale (MCAS) and the
Freezing of Gait Questionnaire (FOG-Q) approximately 1 week
before their visit. They were asked to complete the questionnaires
at home at their convenience. The 6 sub-scores of the SCOPA-
AUT were calculated: gastrointestinal, urinary, cardiovascular,
thermoregulatory, pupillomotor and sexual.
Table 3. Significant predictors of malnutrition (SGA-B) and corresponding odds ratios.
Univariable model Unadjusted OR Final Multivariable model
(95% CI) OR (95% CI)
Gender 1.37 (0.51–3.66)
Living situation 1.50 (0.44–5.10)
Age 1.04 (0.98–1.10)
Age at diagnosis 1.02 (0.973–1.10) 1.09 (1.01–1.18){
PD duration 0.72 (0.94–1.10)
No. comorbid conditions 0.88 (0.23–3.39)
No. of prescription medications 0.34 (0.08–1.59)
LEDD 1.00 (1.00–1.00)
LEDD/weight (mg/kg) 1.09 (1.02–1.17)* 1.17 (1.04–1.31){
UPDRS II 1.08 (1.02–1.14)*
UPDRS III 1.08 (1.02–1.15)* 1.10 (1.02–1.19){
H&Y
(0–3, less severe)
(4 and 5, more severe)
0.19 (0.05–0.77)*
FOG-Q 1.00 (0.91–1.09)
ACE-R 0.96 (0.91–1.01)
MMSE 0.74 (0.58–0.94)*
STAI 1.02 (0.972–1.06) 0.90 (0.82–0.98){
BDI 1.11 (1.04 1.19)* 1.23 (1.07–1.41){
SCOPA-AUT 1.03 (0.97–1.09)
SCOPA-AUT gastrointestinal 1.16 (1.01–1.33)*
SCOPA-AUT urinary 0.99 (0.86–1.14)
SCOPA-AUT cardiovascular 0.92 (0.62–1.34)
SCOPA-AUT thermoregulatory 1.11 (0.88–1.40)
SCOPA-AUT pupillomotor 0.72 (0.37–1.39)
SCOPA-AUT sexual function 1.09 (0.87–1.36)
MCAS 1.15 (0.96–1.38)
*Significant independent predictors of nutritional status (p,.05) in the unadjusted univariable analysis.
{Significant predictors of nutritional status (p,.05) in the multivariable analysis.
Abbreviations: ACE-R =Addenbrooke’s Cognitive Examination-Revised; BDI = Beck’s Depression Inventory; FOG-Q= Freezing of Gait Questionnaire; H&Y=Hoehn & Yahr;
LEDD= levodopa equivalent daily doses; MCAS=Modified Constipation Assessment Scale; MMSE =Mini-Mental State Examination; PD=Parkinson’s disease; SCOPA-
AUT= Scales for Outcomes in Parkinson’s disease – Autonomic; SGA= Subjective Global Assessment; STAI = Spielberger Trait Anxiety Inventory; UPDRS =Unified
Parkinson’s Disease Rating Scale.
doi:10.1371/journal.pone.0057986.t003
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Statistical analysis
Variables of interest were not normally distributed. Therefore,
non-parametric Mann-Whitney U tests were conducted to
compare scores between the groups. Pearson’s Chi square tests
were used to evaluate the differences in categorical variables
except where cell counts were ,5 (H&Y, MCAS satisfaction
rating).
Univariable logistic regression with SGA category (SGA-A,
SGA-B) as the outcome variable was conducted to determine
crude unadjusted odds ratios. Multivariable logistic regression
analysis was performed to include all variables with an identified
association with outcome in the univariable analysis. A final
statistical model, including the most significant variables, was
constructed using the backward elimination procedure.
We also used regression modeling to examine the determinants
of PG-SGA score using the same variables of interest as the logistic
regression. The PG-SGA scores were positively skewed, therefore
the PG-SGA score was log-transformed to produce a normal
distribution. Univariate multifactorial analysis of variance was
conducted using backward elimination to remove the most
insignificant variables from the statistical model to produce the
significant final model for predicting PG-SGA score.
Statistical analysis was completed using SPSS Version 19 (SPSS
Inc., Chicago, IL, USA). Statistical significance was set at p,0.05.
Results
Sample characteristics
Of the 125 participants (73 M, 52 F), 15% (n= 19) were
moderately malnourished (SGA-B), and none were severely
malnourished (SGA-C). Median PG-SGA score was 3 (range 0–
15). Median age of the participants was 70.0 years (range 35.0–
92.0 years), and 73% (n= 91) were aged 65 years or older. Self-
reported median length of disease was 6.0 years (range 0.0–
31.0 years).
Missing data
One participant could not recall when diagnosis had occurred.
Missing assessments included UPDRS II for one participant,
UPDRS III for two participants and ACE-R for three participants.
These participants did not wish to complete the full assessment.
One participant did not complete any of the self-administered
questionnaires (BDI, STAI, SCOPA-AUT, MCAS (including the
MCAS satisfaction rating), FOG-Q). One participant completed
the MCAS but not the satisfaction rating, and one participant
completed all questionnaires but the STAI. Those cases with
missing data were included in the analysis, and missing data were
treated as missing data when that variable was included in the
analysis.
Age and medical characteristics
Age, age at diagnosis and PD duration were not significantly
different between the SGA-A and SGA-B groups. However PG-
SGA score was significantly different (Table 1). More of the
malnourished group were elderly with 84% aged $65 years
compared to 71% of the well-nourished. When comparing the
categorical variables gender, co-morbid conditions, living situation
(alone vs with others) and prescription medications, there were no
differences between the groups (Tables 1, 2). The most common
medical conditions being actively treated were hypertension
(n = 25), history of cardiovascular disease (eg, heart attack,
placement of stents, pacemaker) (n = 23), hypercholesterolemia
(n = 19), osteoporosis (n = 16) and Type 2 diabetes (n = 9). Other
conditions included gastrointestinal dysfunction (total n = 7: n= 3
diverticular disease; n = 1 ulcerative colitis; n = 1 irritable bowel
syndrome; n = 1 Barrett’s esophagus; n = 1 coeliac disease),
hypothyroidism (n= 3) and kidney failure (n = 1). Eleven people
had a history of cancer, but none were undergoing treatment at
the time of the study. LEDD/body weight (mg/kg) were
significantly higher in the malnourished participants, U=1340.0,
z=2.29, p= .022, while LEDD were not.
Cognition and Parkinson’s disease rating scales
The malnourished participants scored significantly lower on the
MMSE, U=551.5, z =22.61, p= .009, as well as on the
visuospatial, U=576.5, z =22.48, p= .013, and attention and
orientation, U=570.0, z=23.03, p= .002 ACE-R sub-scores but
not on the total ACE-R score (Table 2). Both the UPDRS II and
UPDRS III scores were significantly higher in the malnourished
participants (U=1259.5, z = 2.63, p= .009; U=1376.5, z=2.63,
p= .008, respectively). H&Y categorisation (Table 1) was also
significantly different between the groups (Fishers Exact Test
p = 0.03). Severe PD (ie H&Y 4 or 5) was significantly more
common in the malnourished group (OR=5.39 (95%CI= 1.06–
27.05).
Non-motor symptoms
The malnourished participants scored significantly higher on
the BDI (more depressive symptoms) than the well-nourished
participants, U=1457.5, z=3.20, p= .001. The total SCOPA-
AUT score was not significantly different between the groups, but
the gastrointestinal sub-score was significantly higher (more severe
gastrointestinal symptoms) in the malnourished participants,
U=1283.5, z = 2.00, p= .046.
Regression analysis
Unadjusted univariable logistic regression analysis revealed
relationships between several variables and SGA-B (Table 3). The
final multivariable logistic regression model, which included all
significantly associated variables using a backwards elimination
procedure, identified age at diagnosis, LEDD/body weight and
scores for UPDRS III, STAI and BDI as the most significant
predictors of malnutrition (SGA-B) (Table 3).
Regression modelling, used to identify the variables associated
with log-adjusted PG-SGA score, revealed that living situation,
BDI score and UPDRS III score were significant predictors in the
final model (Table 4) with more depressive symptoms and more
severe motor symptoms predictive of poorer nutritional status. The
overall model fit was R2=0.31. UPDRS III and BDI were
therefore predictive of both SGA category and PG-SGA score.
Discussion
This is the largest study to characterise PWP diagnosed with
malnutrition using a nutrition assessment tool, and it is the first to
examine a comprehensive set of potential predictors of nutritional
status, including many PD-specific factors.
The combination of a number of these factors may result in
poor intake and therefore greater nutritional risk. The nutrition
impact section of the PG-SGA score represented the greatest
differences between the well-nourished and malnourished in the
PG-SGA assessment [31], and a number of the symptoms
captured, including nausea, lack of appetite, dysphagia, sensory
changes and constipation are symptoms associated with PD
[12,13]. Therefore, these symptoms are important influencers of
decreased food intake and malnutrition in PD.
These symptoms may have a greater impact on intake as a result
of living situation. Overcoming a lack of motivation to eat may be
Malnutrition Predictors in Parkinson’s Disease
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extremely difficult when there is no one else in the household to
encourage eating.
Depression in PD may contribute to this lack of motivation to
eat, and as in other groups [1], an increase in depressive symptoms
was related to poorer nutritional status in the current sample [14].
Improvements in depression can result in improved body weight
[35]. Conversely, improvements in nutritional status can have
a positive effect on depression due to improved nutrient intake
[36].
Despite the well-documented positive relationship between
depression and anxiety in PWP [37], an increase in depressive
symptoms but a decrease in anxiety were associated with increased
nutrition risk. There has been very limited research regarding the
role of anxiety in malnutrition perhaps due to the large degree of
overlap in the symptoms of depression and anxiety.
Depression and disease severity both emerged as important
factors in all of the relationships explored in the current study
which is not surprising considering that a significant relationship
between the two has previously been reported [37]. Greater
disability in daily tasks such as shopping, cooking and eating
resulting from more severe disease may also exacerbate the effect
of the nutrition impact symptoms and living situation on intake.
Disease severity is related to the age at diagnosis, not age per se
or absolute disease duration. An older age at PD diagnosis
typically results in more rapid motor symptom progression
[38,39]. A person diagnosed at the age of 70 years experiences
an increase of one stage of the H&Y scale in half the time of
someone diagnosed at the age of 50 years [38]. This may explain
the association in the current study between nutritional status and
older age at diagnosis but not age or disease duration. Older age is
also associated with an accelerated loss of lean body mass [40], and
an accelerated deterioration in motor function coupled with
a higher likelihood of lean body mass loss might result in acute and
rapid effects on nutritional status. These results support previous
studies reporting that age was not a significant predictor of
malnutrition risk in PD [14] while age at diagnosis was a significant
predictor of increased weight loss [41].
At the same time, energy expenditure may be increased by the
presence of dyskinesias resulting from increased dopaminergic
treatment, particularly adjusted for body weight [21,42]. In the
current study, LEDD (mg/kg) was significantly higher in the
malnourished group and also increased the odds of being classified
as malnourished. Weight loss may result in an increased risk of
developing dyskinesias [43] that may, in turn, exacerbate weight
loss and the risk of malnutrition. The relationship between LEDD
(mg/kg) and dyskinesias may occur in a dose-response fashion,
with the number of participants experiencing dyskinesia increasing
from 3% to 29% in the lowest to highest quartiles of levodopa
(mg/kg) respectively [43]. It has been suggested that the
adjustment of PD medications to weight changes may be one of
the most important modifiable risk factors for developing
dyskinesias [44], and this may also have positive effects on
nutritional status.
There were also a number of factors that could be expected to
predict nutritional status which were not supported in the current
study. Polypharmacy (.5 medications [3]) is considered a risk
factor in the elderly. Both groups reported a median of 5
prescription medications, and 86% of the participants were
taking 4 or more prescription medications, not only for their
Parkinson’s disease but also for the management of other medical
conditions. The definition of polypharmacy for prognostic
purposes in PWP may require a higher cut-off. Alternatively, it
may not be the absolute number of medications but instead the
amount of dopaminergic medication that plays a role as
previously discussed.
Dementia and poor cognitive function are also typically
considered risk factors for poor nutrition. However, neither
ACE-R nor MMSE scores were significant predictors of
nutritional status or PG-SGA score. This could be due to sampling
bias where PWP with cognitive impairment and/or their spouses
chose not to participate. Only 4 well-nourished (4%) and 2
malnourished (11%) scored #25 points on the MMSE which is
similar to results reported by Wang, et al [14] where the average
MMSE score was not significantly predictive of nutritional status.
Although the presence of dementia according to the ACE-R (#83
points) was higher in each group (27% well-nourished, 47%
malnourished), this also did not influence the nutritional status of
the current sample.
While the total SCOPA-AUT score was not significantly
different between the groups, it was higher in the malnourished
group. A significant contributor to that difference was the
gastrointestinal sub-score. This was reflected in a higher MCAS
score in the malnourished group indicating more bowel
symptoms and resulting in a lower self-rated satisfaction with
bowel function. The greatest number of nutrition impact
symptoms on the PG-SGA in this same sample were constipation
(60%), early satiety (53%), diarrhoea (50%) and loss of appetite
(40%) [31]. Perhaps the SCOPA-AUT is not the best tool by
which to measure the severity of gastrointestinal symptoms [45]
and future studies could include more objective measures of
gastrointestinal dysfunction.
PG-SGA Worksheets 2 (disease conditions) and 3 (metabolic
stress) did not contribute to the overall PG-SGA score in this
sample. Therefore, the triage score for PD may need to be lower
than that in acute diseases, such as cancer and chronic kidney
disease. This should be explored further in future research. The
analysis resulted in motor symptom severity and depressive
symptoms as significant predictors for both SGA and PG-SGA
score. The PG-SGA could potentially be complemented by motor
symptom and depression assessments to determine risk of
malnutrition in PD.
Table 4. Significant predictors of log-adjusted PG-SGA score.
Coefficient 95% Confidence Interval p value
Intercept 0.16 0.03–0.30 .014
Living Situation (referent =with others) 0.14 0.01–0.26 .031
BDI score 0.02 0.01–0.02 .000
UPDRS III score 0.01 0.01–0.02 .000
Abbreviations: BDI = Beck’s Depression Inventory; PG-SGA=Patient Generated Subjective Global Assessment; UPDRS =Unified Parkinson’s Disease Rating Scale.
doi:10.1371/journal.pone.0057986.t004
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Strengths
The strengths of this study include its sample size and inclusion
of a wide range of ages and disease durations. In addition,
a number of potential predictors of nutritional status were
explored with a diagnosis of malnutrition using a nutrition
assessment tool. Previous studies have focused on BMI or weight
loss, and there is already some understanding of factors predicting
lower BMIs or significant amounts of weight loss, but not for
malnutrition per se.
Limitations
Limitations include the fact that the sampling failed to access
the PWP at the more severe end of the disease (H&Y 4, 5).
However, these PWP may already reside in aged care facilities and
therefore are not within the community-dwelling population.
Given that the majority of participants fell within the H&Y 2–3
categories, the application of the current results to PWP in the
other H&Y categorisations should occur with caution.
It is recognised that the risk of malnutrition increases among
patients/residents of acute and aged care facilities [24,46].
Therefore hospitalisation or placement into a long-term facility,
in its own right, could place someone at nutrition risk. The
exclusion of acute care patients and residents of aged care facilities
may under-report the issue in the wider PD population
particularly as PWP in aged care settings tend to have greater
disability and dependency [47]. The aim of this study, however,
was to characterise the issue of malnutrition within community-
dwelling adults living in their own homes. Documenting the issue
may provide the impetus to incorporate regular nutrition
screening processes into community-based health care settings in
order to identify those in need of further assessment and
intervention.
In addition, due to the geographic limitations of the study, the
majority of the participants lived in the urban area of Brisbane,
Queensland and therefore the study did not take into account
potential geographical inequalities in nutritional status. People
living in rural areas may not have similar access to services and
food supplies as urban-dwellers.
Finally, due to the cross-sectional nature of the study, causality
cannot be determined. Many of the factors explored, such as
depression, LEDD/weight and more severe disease status, could
be exacerbated by malnutrition or contribute to malnutrition.
Future longitudinal studies should be conducted to help determine
precedence. And, while a number of factors were included in the
current analysis, the overall model fit for the PG-SGA score was
weak. Additional research could explore in more detail the specific
items (eg non-motor symptoms such as sense of smell and taste,
presence of inflammation and inflammatory cytokines) that
contribute to poor nutritional status.
Recommendations
The relationship between disease severity, depression and
nutritional status warrants a multidisciplinary approach to PD
management including neurologists, psychologists and nutrition
professionals. The effective management of PD symptoms may
have a positive effect on nutritional status, and nutritional status
should not be overlooked in the management of PD symptoms.
Nutrition screening processes should be established in PWP,
particularly in those with more severe disease and depressive
symptoms. Health professionals should provide referrals to
community-based services and Parkinson’s disease support groups
to assist with food-related tasks such shopping and cooking, to
provide the social aspect of eating and to assist with mood. Review
of dopaminergic medication levels should be reviewed with
changes in body weight to prevent unnecessary dyskinesias and
nutritional status decline.
Conclusion
Parkinson’s disease and its management result in a number of
potential risk factors for malnutrition. The malnourished in this
study scored poorer on the majority of the assessments than did
the well-nourished. More severe motor symptoms and more
depressive symptoms were predictive of both malnutrition (SGA-
B) and a higher PG-SGA score. Other factors that contributed to
one or the other were an older age at diagnosis, higher LEDD/
weight and living alone. While nutrition screening should occur for
all PWP, it may be particularly important for the older patients at
diagnosis, those living alone and those who are depressed.
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